Project Grant S10OD040247
- The National Institutes of Health Office of the Director awarded Cornell University $399,750 on May 15, 2026, under the Research Infrastructure Programs (CFDA 93.351) to acquire a LifeCanvas Technologies SmartSPIM lightsheet microscope for the Cornell Biotechnology Resource Center (BRC) Imaging Facility in Ithaca, New York. The microscope will replace an obsolete LaVision Biotec (now Miltenyi) Ultramicroscope II and enable imaging of optically cleared tissues—such as whole mouse brains, lymph...
- The Department of Health and Human Services National Institutes of Health Office of the Director awarded $466,325 to the University of Rochester on May 15, 2026, under the Research Infrastructure Programs (CFDA 93.351) to acquire a Bruker Skyscan 1276 CMOS Edition high-resolution in vivo microCT imaging system. The system will be housed in the Biomechanics and Multimodal Tissue Imaging Core of the Center for Musculoskeletal Research at the University of Rochester School of Medicine and Dentistry...
- This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program provides $287,163 to Cornell University from May 2021 through October 2023. The funding supports research entitled "Enabling More Scans per Machine through Magnetic Resonance Imaging Data Processing." The goal is to advance science and engineering research and innovation leading to breakthrough technologies as well as solutions to national and societal challenges, consistent...
- The National Institutes of Health Office of the Director awarded $3,678,588 to The New York Structural Biology Center, Inc. on July 15, 2026, under the Research Infrastructure Programs (CFDA 93.351) to acquire a gyrotron system for dynamic nuclear polarization (DNP) solid-state nuclear magnetic resonance (NMR) spectroscopy. The gyrotron will be installed on an existing wide-bore 600 megahertz NMR spectrometer at NYSBC in New York, New York, replacing an obsolete instrument installed in...
- The National Institutes of Health Office of the Director awarded The New York Structural Biology Center, Inc. $1.97 million on June 15, 2026, under the Research Infrastructure Programs (CFDA 93.351) to acquire Gatan BioContinuum energy filters for three Titan Krios G2 300-kilovolt cryo-transmission electron microscopes housed at the Simons Electron Microscopy Center (SEMC). The energy filters will extend the capability of the microscopes for high-resolution data collection supporting both...
- The Department of Health and Human Services National Institutes of Health Office of the Director awarded The New York Structural Biology Center, Inc., $1.999 million on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to acquire a Sirius XT SXT-100 soft X-ray microscope for the Simons Electron Microscopy Center (SEMC). The SXT-100 will expand SEMC's correlative microscopy capabilities and enable in situ structural biology studies at near-atomic...
- The National Institute of General Medical Sciences awarded Cornell University $760,645 on September 15, 2025, under the Biomedical Research and Research Training program (CFDA 93.859) to develop algorithms for quantitative recovery of biomolecular structural ensembles from cryo-EM data. The funded research addresses protein conformational change by developing methods to quantitatively recover the probabilities of protein conformational states from cryogenic-sample electron microscopy...
- The National Institutes of Health Office of the Director awarded Michigan State University $1.811 million on June 1, 2026, under the Research Infrastructure Programs (CFDA 93.351) to acquire and install a solid-state cross-polarization magic-angle-spinning cryoprobe and associated upgrade for a 600 MHz NMR spectrometer at the Max T. Rogers NMR Facility in East Lansing, Michigan. The cryoprobe will deliver up to a tenfold sensitivity enhancement, reducing experimental time by as much as...
- The National Institutes of Health Office of the Director awarded the University of Pennsylvania $1,264,944 on July 15, 2026, under the Research Infrastructure Programs (CFDA 93.351) to upgrade its Siemens whole-body 7T TERRA MRI system to the TERRA.X platform at its Center for Advanced Magnetic Resonance Imaging and Spectroscopy (CAMRIS) in Philadelphia. The upgrade includes advanced hardware and software enhancements: AI-powered deep resolve technology, IQ technology, online motion...
- The National Cancer Institute awarded Trustees of Dartmouth College $100,228 on February 14, 2027, under the Cancer Research Manpower program (CFDA 93.398) to develop absolute quantitative oxygen-enhanced MRI (AQOE-MRI), a method combining an FDA-approved oxychip electron paramagnetic resonance spin probe with relaxometry measurements to generate absolute PO2 values for mapping tumor hypoxia and guiding radiation therapy dose escalation. The project runs through August 16, 2028, and is performed...
The National Institutes of Health Office of the Director awarded $956,000 to Advanced Center For Electron Spin Resonance Research And Technology, Inc. on September 1, 2026, under the Research Infrastructure Programs (CFDA 93.351) to purchase and install a pulsed electron spin resonance oxygen imaging system (ESROI) at Cornell University's Cornell Magnetic Resonance Imaging Facility (CMRIF). The ESROI system is the only commercially available ESR-based oxygen imager and will be the first installed in the Northeast United States. It enables fast, non-invasive three-dimensional partial pressure of oxygen (PO2) mapping with high spatial and temporal resolution across in vitro, in vivo, and ex vivo sample types. The system will serve research groups across Cornell, Upstate New York, Greater New York City, and the Northeast region, supporting NIH-funded projects including mitochondrial dysfunction in articular cartilage health and disease; non-invasive tissue oxygen measurement in acute cardiopulmonary diseases; islet function upon transplantation; image-guided light dosimetry in interstitial photodynamic therapy for locally advanced cancer; mitochondrial dysfunction in osteolineage cells during aging; spatially fractionated radiotherapy in osteosarcoma; and root-zone oxygen dynamics in plant sciences. The award is administered by the National Resource for Advanced Electron Spin Resonance Spectroscopy (ACERT), which operates under an NIH R24 award. Performance occurs in Ithaca, New York with a period of performance from September 1, 2026 through August 31, 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $956.0k | 9/2/26 |